The Open Clinical Tests for the Safety of Kurozu-containing Food

S. Abe, Y. Matsumoto, S. Koyanagi
{"title":"The Open Clinical Tests for the Safety of Kurozu-containing Food","authors":"S. Abe, Y. Matsumoto, S. Koyanagi","doi":"10.1625/JCAM.16.7","DOIUrl":null,"url":null,"abstract":"The Open Clinical Tests for the Safety of Kurozu-containing Food Shoko ABE, Yoshiyuki MATSUMOTO, Satoshi KOYANAGI EGAO Health Institute Two different types of clinical safety test of Kurozu-containing food were done. Under the informed consent, following tests were conducted, Test 1; Ten healthy adults were orally administrated 10 capslues/day of Kurozu for 4 weeks, Test 2; Ten patients with hepatitis C and 10 patients with mild hepatic dysfunction were orally administrated 2 capslues/day of Krozu for 4 weeks. In both the Test1 and Test2, Vital sign including Blood pressure etc, blood cell count, blood chemical analysis, and urinalysis were performed. In both tests, there were no abnormal findings. Furthermore, no side effect was observed. In conclusion, safety of Kurozu-containing food was confirmed.","PeriodicalId":224142,"journal":{"name":"Japanese Journal of Complementary and Alternative Medicine","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Japanese Journal of Complementary and Alternative Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1625/JCAM.16.7","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The Open Clinical Tests for the Safety of Kurozu-containing Food Shoko ABE, Yoshiyuki MATSUMOTO, Satoshi KOYANAGI EGAO Health Institute Two different types of clinical safety test of Kurozu-containing food were done. Under the informed consent, following tests were conducted, Test 1; Ten healthy adults were orally administrated 10 capslues/day of Kurozu for 4 weeks, Test 2; Ten patients with hepatitis C and 10 patients with mild hepatic dysfunction were orally administrated 2 capslues/day of Krozu for 4 weeks. In both the Test1 and Test2, Vital sign including Blood pressure etc, blood cell count, blood chemical analysis, and urinalysis were performed. In both tests, there were no abnormal findings. Furthermore, no side effect was observed. In conclusion, safety of Kurozu-containing food was confirmed.
含黑螨食品安全性的公开临床试验
含黑霉菌食品安全性的公开临床试验ABE Shoko, Yoshiyuki MATSUMOTO, Satoshi KOYANAGI EGAO健康研究所对含黑霉菌食品进行了两种不同类型的临床安全性试验。在知情同意下,进行了以下测试:测试1;10名健康成人口服黑津10粒/天,连续4周,试验2;10例丙型肝炎患者和10例轻度肝功能障碍患者口服Krozu 2粒/天,疗程4周。在Test1和Test2中进行生命体征(包括血压等)、血细胞计数、血液化学分析和尿液分析。两项检查均未发现异常。此外,没有观察到副作用。综上所述,证实了含黑霉菌食品的安全性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书